Five phase 3 trials presented at ESMO 2026 showed new options in small cell lung, bladder, prostate, KRAS G12C lung and ...
For patients with hairy cell leukemia whose cancer returns after multiple treatments, researchers are investigating whether ...
For people with lung or pancreatic cancer driven by changes in the KRAS gene, research presented at the 2026 European Society ...
Researchers are exploring new options for patients with relapsed or refractory hairy cell leukemia, including chimeric ...
Adding Imdelltra (tarlatamab) to Imfinzi (durvalumab) maintenance therapy helped people with extensive-stage small cell lung ...
The FDA previously approved FoundationOne CDx, which uses a tumor tissue sample, and FoundationOne Liquid CDx, which uses a ...
Many people keep working during cancer treatment, return to work afterward or take time off to care for a loved one with cancer. Two federal laws, the Family and Medical Leave Act (FMLA) and the ...
He thought CAR-T therapy marked the end of cancer. Months later, another diagnosis revealed the power of faith, hope and resilience.
Be The Match® is a community of donors, volunteers, health care professionals and researchers who deliver cures by helping patients get the life-saving marrow or umbilical cord blood transplant they ...
An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer. A simple blood test can help oncologists track how ...
After 19 years of survivorship, one cancer survivor reflects on life's changing seasons, managing scan anxiety and finding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results